These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17593814)

  • 41. Fulvestrant reverses doxorubicin resistance in multidrug-resistant breast cell lines independent of estrogen receptor expression.
    Huang Y; Jiang D; Sui M; Wang X; Fan W
    Oncol Rep; 2017 Feb; 37(2):705-712. PubMed ID: 28000875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activity of taspine isolated from Radix et Rhizoma Leonticis against estrogen-receptor-positive breast cancer.
    Zhan Y; Zhang Y; Chen Y; Wang N; Zheng L; He L
    Fitoterapia; 2011 Sep; 82(6):896-902. PubMed ID: 21605638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer.
    Lu Q; Zhang P; Zhang X; Chen J
    Int J Mol Med; 2009 Dec; 24(6):773-80. PubMed ID: 19885617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of anthocyanins, derivative pigments and other catechol and pyrogallol-type phenolics on breast cancer cell proliferation.
    Fernandes I; Faria A; Azevedo J; Soares S; Calhau C; De Freitas V; Mateus N
    J Agric Food Chem; 2010 Mar; 58(6):3785-92. PubMed ID: 20170107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and potential cytotoxic activity of new phenanthrylphenol-pyrrolobenzodiazepines.
    Kamal A; Sreekanth K; Kumar PP; Shankaraiah N; Balakishan G; Ramaiah MJ; Pushpavalli SN; Ray P; Bhadra MP
    Eur J Med Chem; 2010 Jun; 45(6):2173-81. PubMed ID: 20171761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cancer chemo-endocrine therapy and its cell biological basis].
    Nishiya I
    Hum Cell; 1998 Sep; 11(3):109-14. PubMed ID: 10086273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle.
    Yang M; Gao H; Chen P; Jia J; Wu S
    Oncol Rep; 2013 Jul; 30(1):171-8. PubMed ID: 23624618
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tamoxifen reduces P-gp-mediated multidrug resistance via inhibiting the PI3K/Akt signaling pathway in ER-negative human gastric cancer cells.
    Mao Z; Zhou J; Luan J; Sheng W; Shen X; Dong X
    Biomed Pharmacother; 2014 Mar; 68(2):179-83. PubMed ID: 24184201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytotoxicity and mechanism of action of a new ROS-generating microsphere formulation for circumventing multidrug resistance in breast cancer cells.
    Liu Q; Shuhendler A; Cheng J; Rauth AM; O'Brien P; Wu XY
    Breast Cancer Res Treat; 2010 Jun; 121(2):323-33. PubMed ID: 19618264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel microtubule inhibitor SQ overcomes multidrug resistance in MCF-7/ADR cells by inhibiting BCRP function and mediating apoptosis.
    Chang X; Liu Z; Cao S; Bian J; Zheng D; Wang N; Guan Q; Wu Y; Zhang W; Li Z; Zuo D
    Toxicol Appl Pharmacol; 2022 Feb; 436():115883. PubMed ID: 35031325
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [A study on the effect of Tanshinone II A against human breast cancer in vivo].
    Zhang X; Zhang PR; Chen J; Lü Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):62-7. PubMed ID: 20369472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Reversal effect and mechanism of lobeline on the multidrug-resistance of human breast cancer cells MCF-7/ADM].
    Chen J; Shen L; Zhou R; Yao W; Zhong M; Zhu ZH; Zeng S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Aug; 34(8):738-43. PubMed ID: 19734580
    [TBL] [Abstract][Full Text] [Related]  

  • 53. G0/G1 arrest and S phase inhibition of human cancer cell lines by inositol hexaphosphate (IP6).
    El-Sherbiny YM; Cox MC; Ismail ZA; Shamsuddin AM; Vucenik I
    Anticancer Res; 2001; 21(4A):2393-403. PubMed ID: 11724298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Down-regulation of tumor-associated NADH oxidase, tNOX (ENOX2), enhances capsaicin-induced inhibition of gastric cancer cell growth.
    Wang HM; Chuang SM; Su YC; Li YH; Chueh PJ
    Cell Biochem Biophys; 2011 Nov; 61(2):355-66. PubMed ID: 21735133
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antineoplastic effects of α-santalol on estrogen receptor-positive and estrogen receptor-negative breast cancer cells through cell cycle arrest at G2/M phase and induction of apoptosis.
    Santha S; Bommareddy A; Rule B; Guillermo R; Kaushik RS; Young A; Dwivedi C
    PLoS One; 2013; 8(2):e56982. PubMed ID: 23451128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stilbenes as multidrug resistance modulators and apoptosis inducers in human adenocarcinoma cells.
    Wesolowska O; Wisniewski J; Bielawska-Pohl A; Paprocka M; Duarte N; Ferreira MJ; Dus D; Michalak K
    Anticancer Res; 2010 Nov; 30(11):4587-93. PubMed ID: 21115910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of antidiabetic drug metformin on human breast carcinoma cells with different estrogen receptor expressing in vitro].
    Wang Y; Zhang MX; Duan XY; Zhou SN; Ermek T; Wang YN; Cai H; Wang JS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Mar; 27(3):253-6. PubMed ID: 21419041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Rab23 on the proliferation and apoptosis in breast cancer.
    Liu Y; Zeng C; Bao N; Zhao J; Hu Y; Li C; Chi S
    Oncol Rep; 2015 Oct; 34(4):1835-44. PubMed ID: 26238143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Centchroman mediated apoptosis involves cross-talk between extrinsic/intrinsic pathways and oxidative regulation.
    Nigam M; Singh N; Ranjan V; Zaidi D; Sharma R; Nigam D; Gupta DK; Sundaram S; Balapure AK
    Life Sci; 2010 Dec; 87(23-26):750-8. PubMed ID: 21034746
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel anti-cancer agent, acetyltanshinone IIA, inhibits oestrogen receptor positive breast cancer cell growth by down-regulating the oestrogen receptor.
    Yu T; Zhou Z; Mu Y; de Lima Lopes G; Luo KQ
    Cancer Lett; 2014 Apr; 346(1):94-103. PubMed ID: 24374015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.